Back to Search
LUKE HIGGINS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1104575554Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
4351050472(MI)5315238889(MI)
Research & Publications (20)
Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase.
PMID 19361351·Curr Atheroscler Rep·2009
6-review
The Development of INT131 as a Selective PPARgamma Modulator: Approach to a Safer Insulin Sensitizer.
PMID 18769500·PPAR Res·2008
8-other
Structural insight into antibiotic fosfomycin biosynthesis by a mononuclear iron enzyme.
PMID 16015285·Nature·2005
8-other
An assessment of the reaction energetics for cytochrome P450-mediated reactions.
PMID 11361021·Arch Biochem Biophys·2001
8-other
Prospective evaluation of a colorectal cancer nurse follow-up clinic.
PMID 19674021·Colorectal Dis·2011
8-other
Avoidance and treatment of complications in shoulder arthroplasty.
PMID 19385555·Instr Course Lect·2009
8-other
Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.
PMID 19273909·J Clin Invest·2009
7-preclinical
Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
PMID 19587643·Clin Pharmacol Ther·2009
8-other
Hypoxia and the metabolic phenotype of prostate cancer cells.
PMID 19524545·Biochim Biophys Acta·2009
7-preclinical
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.
PMID 19104814·Cancer Chemother Pharmacol·2009
3-trial
Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents.
PMID 19303893·Toxicol Appl Pharmacol·2009
4-observational
Soft-tissue resurfacing of the glenoid in the treatment of glenohumeral arthritis in active patients less than fifty years old.
PMID 19181986·J Bone Joint Surg Am·2009
8-other
Conidiation color mutants of Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria mellonella.
PMID 19156203·PLoS One·2009
7-preclinical
Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing.
PMID 19167815·Pain·2009
7-preclinical
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation.
PMID 18812596·J Lipid Res·2009
8-other
Insights into the capillary electrophoresis separation of heparin disaccharides from nuclear magnetic resonance, pKa, and electrophoretic mobility measurements.
PMID 19653663·Anal Chem·2009
8-other
Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds.
PMID 19608619·Carcinogenesis·2009
8-other
Prevalence of cerebrovascular events during shoulder surgery and association with patient position.
PMID 19388618·Orthopedics·2009
8-other
Results of arthroscopic capsulolabral repair: Bankart lesion versus anterior labroligamentous periosteal sleeve avulsion lesion.
PMID 18971059·Arthroscopy·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4300
Quick Facts
- NPI
- 1104575554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile